Amin Dipti 4
4 · Lineage Cell Therapeutics, Inc. · Filed Jul 3, 2023
Insider Transaction Report
Form 4
Amin Dipti
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-07-01+50,000→ 50,000 totalExercise: $1.41Exp: 2033-07-01→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer.